Article Text

Download PDFPDF

Disease modification in multiple sclerosis: an update
  1. Claire M Rice
  1. Correspondence to Dr Claire M Rice, Institute of Clinical Neurosciences, University of Bristol, Frenchay Hospital, Bristol BS16 1JB, UK; c.m.rice{at}bristol.ac.uk

Abstract

Although there has been unequivocal progress in the development of treatments for multiple sclerosis over the last 20 years, currently licensed treatments have demonstrated convincing effects on disease course only with reference to relapse frequency. This review summarises the progress made, highlights the indications for, and limitations of, current disease-modifying therapies and discusses some interventions currently in development.

  • Multiple Sclerosis
  • Pharmacology
View Full Text

Statistics from Altmetric.com

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Editors' choice
    Phil Smith Geraint N Fuller